Don’t miss this overview of the Department of Energy SBIR/STTR program, featuring DOE’s Outreach Program Manager, Eileen Chant. Learn how to prepare quality, fund-able applications and realize best practices and common pitfalls to avoid! This webinar is ideal for researchers and small businesses interested in getting R&D funding for their innovative solution.
The yearly contest from the Office of the Vice Chancellor for Research and Graduate Education funds select research projects across each faculty division — biological sciences, physical sciences, social sciences and the arts and humanities. It is open to tenured professors and associate professors, tenure-track assistant professors and permanent PIs, and encourages collaboration.
Are you a campus researcher, problem-solver, inventor, maker, entrepreneur, or social impact innovator? Are you looking to maximize impact for your research, turn your idea into a product or service, or start a company or organization? Discover inspiring stories and practical tools to advance your idea at Innovate Week (October 4 – 8, 2021), coordinated by UW Discovery to Product (D2P) and the UW Innovate Network.
This workshop will provide detailed instruction on developing competitive proposals for the National Institutes of Health’s (NIH) SBIR/STTR program. In addition to up-to-date information on the SBIR/STTR programs. This session is a must if you are considering an NIH submission.
Join Caroline Chen, health care reporter for ProPublica and UW–Madison’s fall 2021 Science Writer in Residence, and a panel of campus experts for a hybrid event focused on how we communicate and make sense of numbers and other data, especially during the rapidly evolving pandemic and amidst a steady stream of misinformation.
Join NCATS for a panel discussion with SBIR/STTR grantees who have used NCATS funding and resources to develop transformative innovations in translational science. Hear about their innovations, their inspirations, and the lessons they have learned while building their businesses, Recursion Pharmaceuticals, Intabio and GoDX.